全文获取类型
收费全文 | 48973篇 |
免费 | 3767篇 |
国内免费 | 1786篇 |
专业分类
耳鼻咽喉 | 332篇 |
儿科学 | 766篇 |
妇产科学 | 830篇 |
基础医学 | 2866篇 |
口腔科学 | 393篇 |
临床医学 | 5110篇 |
内科学 | 8323篇 |
皮肤病学 | 338篇 |
神经病学 | 2012篇 |
特种医学 | 1163篇 |
外国民族医学 | 6篇 |
外科学 | 2988篇 |
综合类 | 8355篇 |
现状与发展 | 6篇 |
预防医学 | 3209篇 |
眼科学 | 1042篇 |
药学 | 10685篇 |
43篇 | |
中国医学 | 5104篇 |
肿瘤学 | 955篇 |
出版年
2024年 | 107篇 |
2023年 | 640篇 |
2022年 | 1005篇 |
2021年 | 1988篇 |
2020年 | 1644篇 |
2019年 | 1400篇 |
2018年 | 1560篇 |
2017年 | 1669篇 |
2016年 | 1866篇 |
2015年 | 1812篇 |
2014年 | 3674篇 |
2013年 | 3778篇 |
2012年 | 3653篇 |
2011年 | 3839篇 |
2010年 | 2941篇 |
2009年 | 2542篇 |
2008年 | 2440篇 |
2007年 | 2364篇 |
2006年 | 2077篇 |
2005年 | 1819篇 |
2004年 | 1408篇 |
2003年 | 1217篇 |
2002年 | 1031篇 |
2001年 | 924篇 |
2000年 | 696篇 |
1999年 | 616篇 |
1998年 | 476篇 |
1997年 | 458篇 |
1996年 | 398篇 |
1995年 | 374篇 |
1994年 | 355篇 |
1993年 | 280篇 |
1992年 | 245篇 |
1991年 | 262篇 |
1990年 | 241篇 |
1989年 | 199篇 |
1988年 | 213篇 |
1987年 | 189篇 |
1986年 | 163篇 |
1985年 | 266篇 |
1984年 | 229篇 |
1983年 | 163篇 |
1982年 | 190篇 |
1981年 | 157篇 |
1980年 | 154篇 |
1979年 | 131篇 |
1978年 | 100篇 |
1977年 | 103篇 |
1976年 | 95篇 |
1975年 | 74篇 |
排序方式: 共有10000条查询结果,搜索用时 288 毫秒
11.
12.
Aditya Kelkar Caroll Webers Rohit Shetty Jai Kelkar Nikhil Labhsetwar Abhishek Pandit Madhulika Malode Sayali Tidke 《Indian journal of ophthalmology》2020,68(10):2143
Purpose:To evaluate the rate of compliance and the reasons for loss to follow-up in Indian patients with diabetic macular edema (DME), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) being treated with anti-vascular endothelial growth factor (VEGF) therapy.Methods:This was a retrospective single-center study. Patients with DME, AMD, or RVO were eligible if they initiated anti-VEGF therapy between January 2013 and December 2017. Patients'' data were obtained from hospital electronic records, including the number of injections received, visits, details of follow-up, missed appointments, and reasons for loss to follow-up (>365 days).Results:A total of 648 patients were eligible for the study, of which 334 (51.54%) patients were lost to follow-up. Overall, 343 (64.96%) were males and the overall mean (SD) age was 66.40 (7.44) years. A total of 376 (58.0%) patients had a history of diabetes and 364 (56.2%) patients had a history of hypertension. Further, 127 (38.0), 112 (33.5), and 95 (28.4) had DME, AMD, and RVO, respectively and were lost to follow-up. The most commonly reported reason for loss to follow-up was “non-affordability” (n = 120; 41.1%) followed by “no improvement in vision” (n = 83; 28.4%). “No improvement in vision” (42.2%) and “non-affordability” (37.5%) were higher among patients with DME. No association was found in gender- and treatment-wise distribution of reasons for loss to follow-up.Conclusion:The results showed that around half of the patients with DME, AMD, and RVO were lost to follow-up to intravitreal anti-VEGF therapy, and the most common factors were “non-affordability” and “no improvement in vision.” 相似文献
13.
14.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
15.
【摘要】 目的 了解社区中老年人群的血脂、血糖现状水平,探讨其与性别和年龄的关系,为本地区心脑血管疾病、糖尿病等疾病的防治提供诊疗依据。方法 对我市38078名社区居民采集清晨空腹血清标本,检测血糖(GLU)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL C)和低密度脂蛋白胆固醇(LDL C)的结果,并对其进行年龄、性别分组统计分析。结果 不同性别和年龄组间的血脂、血糖水平差异有统计学意义(P<005),74~89岁年龄组血脂、血糖总体水平高于其他各年龄组(P<005);女性血脂水平普遍高于男性(P<005)。结论 中老年人群血脂、血糖异常率高,应定期对中老年人进行血脂、血糖监测,开展宣传教育活动,提高自我保健意识,预防高血脂、高血糖的发生和发展。 相似文献
16.
Matrine,oxymatrine, and compound Kushen injection from the roots of Sophora flavescens: an overview of their anticancer activities 下载免费PDF全文
In the present review, we updated current information on the chemistry, contents, and anticancer properties of matrine (MT), oxymatrine (OMT), and compound Kushen injection (CKI). The anticancer properties were focused on lung, breast, and liver cancer cells because they are most susceptible. Sources of information were from Google, Google Scholar, PubMed, PubMed Central, Science Direct, PubChem, J-Stage, Directory of Open Access Journals (DOAJ), and China National Knowledge Infrastructure (CNKI). Reference was also made on botanical websites, such as Flora of China and World Flora Online. MT and OMT are dominant quinolizidine alkaloids from the roots of Sophora flavescens (Kushen) of the family Fabaceae. Against lung, breast, and liver cancer cells, MT and OMT inhibit cell proliferation; induce cell cycle arrest, apoptosis, and autophagy; restrict angiogenesis; and inhibit cell metastasis, invasion, and migration. The processes involve various molecular targets and signaling pathways. CKI is a traditional Chinese medicine (TCM) composed of root extracts of S. flavescens and Smilax glabra (Baituling) of the family Smilacaceae. With MT and OMT as major components, CKI has been approved for the treatment of cancer in China more than 20 years ago. In recent years, systematic reviews and meta-analysis have been undertaken to evaluate the anticancer effects of CKI. When CKI is used alone and in combination with chemotherapy of western medicine, there is much to be learned concerning their interactions besides their individual and integrated efficacy. Some perspectives of MT, OMT, and CKI are discussed, and their suggestions for future research are provided. 相似文献
17.
18.
19.
Siti Nurhuda Sharudin Mohamad Fathi Ismail Suresh Kumar Vasudevan 《Neuro-ophthalmology (Aeolus Press)》2019,43(2):102-106
The rise in popularity of hyaluronic acid (HA) dermal filler injection has caused an exceptional increase in the number of cases of reported irreversible blindness. Here, we reported a case of ischemic optic neuropathy and ophthalmoplegia following subcutaneous HA filler injection with complete visual recovery. A 31-year-old Chinese woman presented with sudden onset of right monocular visual impairment associated with diplopia. Patient had received a hyaluronic acid-containing ?ller injection for nasal dorsum augmentation twelve hours prior to presentation. Visual acuity of the right eye was counting finger. A right relative afferent pupillary defect was demonstrated with ophthalmoplegia. Humphrey visual field test disclosed a right inferior altitudinal field defect with impairment of colour vision. Computed tomography of the orbit revealed mild enlargement of the right medial and inferior recti muscles. Our patient showed a tremendous improvement of vision after a subcutaneous hyaluronidase injection with complete visual recovery within 2 weeks. 相似文献
20.